Mayo, Muiz U.

HRN: 20-92-33  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
11/17/2025
11/24/2025
ORAL
8ml
Q8
Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: